CANCER. Tumor angiogenesis, from foe to friend.
Department of Neurological Surgery, Brain Tumor Research Center, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA. lee.rivera@ucsf.edu gabriele.bergers@ucsf.edu.
Lee B
LB
Rivera
Department of Neurological Surgery, Brain Tumor Research Center, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA. lee.rivera@ucsf.edu gabriele.bergers@ucsf.edu.
Gabriele
G
Bergers
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D015687:Cell Hypoxia; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000098:blood supply; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D012910:Snake Venoms / Q000008:administration & dosage / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D012910:Snake Venoms; C422910:Cilengitide